[632] IMPACT OF TARIBAVIRIN EXPOSURE ON EFFICACY, ANEMIA RATES, AND Gl SIDE EFFECTS WHEN USED WITH PEGYLATED INTERFERON ALFA-2b FOR THE TREATMENT OF CHRONIC HEPATITIS C

2007 ◽  
Vol 46 ◽  
pp. S239 ◽  
Author(s):  
P. Pockros ◽  
M. Rodrigues-Torres ◽  
Y. Lurie ◽  
S. Gordon ◽  
M. Shiffman ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Side Effects ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Pegylated Interferon Alfa

scholarly journals Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents

2010 ◽  
Vol 9 (2) ◽  
pp. 156-160 ◽  
Author(s):  
Jaber Al Ali ◽  
Salem Owayed ◽  
Wafa’a Al-Qabandi ◽  
Khaled Husain ◽  
Fuad Hasan
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Genotype 4 ◽  
Pegylated Interferon Alfa

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4

2009 ◽  
Vol 81 (9) ◽  
pp. 1576-1583 ◽  
Author(s):  
Hesham El Makhzangy ◽  
Gamal Esmat ◽  
Mohamed Said ◽  
Maissa ElRaziky ◽  
Soheir Shouman ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Genotype 4 ◽  
Pegylated Interferon Alfa
Sign in / Sign up

Export Citation Format

Share Document